4D Molecular Therapeutics
FDMT
FDMT
80 hedge funds and large institutions have $395M invested in 4D Molecular Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
27% less capital invested
Capital invested by funds: $541M → $395M (-$146M)
Holders
80
Holding in Top 10
2
Calls
$1.79M
Puts
–
Top Buyers
| 1 | +$10.3M | |
| 2 | +$8.61M | |
| 3 | +$3.86M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.61M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.51M |
Top Sellers
| 1 | -$3.29M | |
| 2 | -$2.9M | |
| 3 | -$2.19M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$883K |
| 5 |
Two Sigma Investments
New York
|
-$866K |